288 related articles for article (PubMed ID: 9613753)
1. Extensor truncal dystonia: successful treatment with botulinum toxin injections.
Comella CL; Shannon KM; Jaglin J
Mov Disord; 1998 May; 13(3):552-5. PubMed ID: 9613753
[TBL] [Abstract][Full Text] [Related]
2. Treatment of nonoccupational limb and trunk dystonia with botulinum toxin.
Quirk JA; Sheean GL; Marsden CD; Lees AJ
Mov Disord; 1996 Jul; 11(4):377-83. PubMed ID: 8813216
[TBL] [Abstract][Full Text] [Related]
3. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
4. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
[TBL] [Abstract][Full Text] [Related]
5. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin A--injection for cervical dystonia.
Bhaumik S; Behari M
J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor.
Wissel J; Masuhr F; Schelosky L; Ebersbach G; Poewe W
Mov Disord; 1997 Sep; 12(5):722-6. PubMed ID: 9380055
[TBL] [Abstract][Full Text] [Related]
8. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia.
Gilio F; Currà A; Lorenzano C; Modugno N; Manfredi M; Berardelli A
Ann Neurol; 2000 Jul; 48(1):20-6. PubMed ID: 10894212
[TBL] [Abstract][Full Text] [Related]
9. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin.
Tarsy D
Mov Disord; 1997 Jan; 12(1):100-2. PubMed ID: 8990061
[TBL] [Abstract][Full Text] [Related]
11. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
[TBL] [Abstract][Full Text] [Related]
12. Management of dystonia of the lateral pterygoid muscle with botulinum toxin A.
Mendes RA; Upton LG
Br J Oral Maxillofac Surg; 2009 Sep; 47(6):481-3. PubMed ID: 18829144
[TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients].
Novis SA; De Mattos JP; De Rosso AL
Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813
[TBL] [Abstract][Full Text] [Related]
14. Botulinum A toxin treatment in spasmodic torticollis: report of 56 patients.
Poungvarin N; Viriyavejakul A
J Med Assoc Thai; 1994 Sep; 77(9):464-70. PubMed ID: 7706965
[TBL] [Abstract][Full Text] [Related]
15. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
[TBL] [Abstract][Full Text] [Related]
16. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
Sankhla C; Jankovic J; Duane D
Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
[TBL] [Abstract][Full Text] [Related]
17. Influence of age and gender on dose and effectiveness of botulinum toxin for laryngeal dystonia.
Vasconcelos S; Birkent H; Sardesai MG; Merati AL; Hillel AD
Laryngoscope; 2009 Oct; 119(10):2004-7. PubMed ID: 19572275
[TBL] [Abstract][Full Text] [Related]
18. No effects on heart-rate variability and cardiovascular reflex tests after botulinum toxin treatment of cervical dystonia.
Nebe A; Schelosky L; Wissel J; Ebersbach G; Scholz U; Poewe W
Mov Disord; 1996 May; 11(3):337-9. PubMed ID: 8723158
[No Abstract] [Full Text] [Related]
19. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
Rosales RL; Ng AR; Santos MM; Fernandez HH
Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]